Large platform vs smaller platform
Gala vs IVIM Health: Track Record and Scale Compared (2026)
Gala costs $2,988 a year against $2,013 for IVIM Health. Full 2026 comparison of price, medication class and included support.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.7 and 7.2 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Gala versus IVIM Health is a common shortlist, and it is a more interesting one than the two homepages suggest.
IVIM Health carries 36,958 patient reviews against 2,870 at Gala. Volume is not quality, but it is the difference between a platform that has already handled your edge case and one that may not have seen it.
The sections that follow price both programs across a full course of treatment rather than a first month, then set out which patient each one is actually built for. Where a provider quotes only after intake, that is recorded as the answer rather than replaced with a guess.
The short answer
- Lowest 12-month cost
- IVIM Health — $2,013 against $2,148 at Gala, on each provider's own best published pricing.
- Most support for the money
- Gala — Provider check-ins and dose monitoring included.
- Fastest route to a first shipment
- Gala — Fully online, no in-office visits, then home delivery.
- Widest medication choice
- Gala — compounded semaglutide and compounded tirzepatide.
Gala vs IVIM Health at a glance
The table is built from each provider's published pricing and program detail; anything they decline to state is marked as such.
| Gala | IVIM Health | |
|---|---|---|
| Advertised price | From $249/mo, as low as $179/mo on longer plans | $99 first month, then $174/mo |
| Rate after promotions | $249/mo | $174/mo |
| Pricing structure | Cheaper per month the longer you commit | Membership fee plus the cost of medication |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| How fast you start | Fully online, no in-office visits | Free consult, then clinician review |
| State coverage | Not published | Not published |
| Payment options | Card only, no financing published | Card only, no financing published |
| Membership fee | None | Yes, billed separately |
| Patient reviews | 2,870 | 36,958 |
| eRxDoctor score | 7.7/10 | 7.2/10 |
What you will have spent by month twelve
GLP-1 treatment is not a one-month purchase, and neither of these prices it like one. These are the totals — six months and twelve — using each provider's own published rates and best available plan.
| Gala | IVIM Health | |
|---|---|---|
| First month | $249 | $99 |
| Months 2 onward | $249/mo | $174/mo |
| 6-month total | $1,494 | $969 |
| 12-month total | $2,988 | $2,013 |
| Best published plan | longer-term plan at $179/mo — $2,148/yr | No multi-month discount published |
Over a year that is a $135 difference, in IVIM Health's favor. Whether it is the right call depends on whether Gala gives you $11 a month of something you will use.
Price escalation to plan for: IVIM Health moves from $99 to $174, a 76% increase. Set a calendar reminder for the month it changes.
Track record, and what review volume is worth
IVIM Health has 36,958 reviews on record against 2,870 for Gala. Star ratings sit close together across this whole market, so the count is more informative than the score: it tells you how many times the operation has been tested.
Scale matters in this category for unglamorous reasons — pharmacy relationships that hold when demand spikes, support that answers on a Sunday, and a refund process that exists. Gala may run all of that well; there is simply less public evidence either way, and there is the standing caveat that the entry price sits above most compounded competitors unless you commit to a longer term.
The counterweight is that smaller platforms often provide more direct clinician access, and Gala leads with a direct-pay model with dose monitoring included rather than sold as an add-on.
Gala: what you are buying
Gala GLP-1 is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide with provider check-ins and home delivery. What it is really selling here is a direct-pay model with dose monitoring included rather than sold as an add-on.
You start with fully online, no in-office visits; medication arrives via home delivery. The price behaves as cheaper per month the longer you commit.
Ongoing care is provider check-ins and dose monitoring included, and the medication list runs to compounded semaglutide and compounded tirzepatide.
Gala pros
- Fully online, no in-office visits required
- Direct-pay model, no insurance or prior authorizations needed
- Provider check-ins and dose monitoring included
Gala cons
- Lower long-term pricing requires a multi-month commitment
- Higher entry price than several compounded competitors
Against IVIM Health specifically, the trade you are making: the entry price sits above most compounded competitors unless you commit to a longer term.
How IVIM Health works
Limited Offer: Free Month Membership – Use Code GIFT75 Against Gala, that puts it in the position of the cheaper option.
From signup to first shipment: free consult, then clinician review, then home delivery. Billing follows a membership fee plus the cost of medication structure.
Behind the prescription sits no-obligation free consultation valued at $75. Available medication: compounded semaglutide.
IVIM Health pros
- Proprietary GLP-1 ID protocol claiming up to 40% faster weight loss
- Free month membership with code GIFT75
- No-obligation free consultation ($75 value) for new patients
- 4.9-star rating on both Google and Trustpilot, rare dual third-party verification
IVIM Health cons
- Compounded medication only, no branded Ozempic or Wegovy
- The 40% faster claim is a proprietary protocol claim, not an independent clinical finding
- Price rises from $99 first month to $174/month ongoing
Set beside Gala, the thing to weigh: the GLP-1 ID protocol's 40% faster claim is the platform's own, not an independent finding.
Which one fits which patient
Choose Gala if:
- delivery works the way you want it to: home delivery
- you want to start on their timeline: fully online, no in-office visits
- you want a single monthly charge rather than a membership plus medication
- you are willing to commit for a term in exchange for a lower effective rate (longer-term plan at $179/mo)
Choose IVIM Health if:
- the monthly rate is the constraint — $174/mo against $249/mo
- you would rather use the platform with the longer public record (36,958 reviews)
- the twelve-month total is what you are optimizing ($2,013 against $2,988)
- what it leads on is worth paying for in your case: 4.9 stars on both Google and Trustpilot, which is rare dual third-party verification
The trade-offs, stated plainly
On price. $174/mo against $249/mo. Gala is asking you to pay for a direct-pay model with dose monitoring included rather than sold as an add-on; decide whether that is a line item you will use.
On commitment. Gala rewards a longer commitment (longer-term plan at $179/mo), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On access. Gala advertises fully online, no in-office visits and home delivery; IVIM Health advertises free consult, then clinician review and home delivery. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
On predictability. The pricing structures differ (cheaper per month the longer you commit versus membership fee plus the cost of medication), and structure, not headline rate, determines the twelve-month bill.
What the trials and the FDA say
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
Compounding is lawful within a specific statutory framework, and the conditions attached to it have changed as GLP-1 shortages have resolved, per FDA.
Compounded medication occupies a different regulatory category entirely: no approval application, and no FDA verification of what is in the vial, per FDA.
Read alongside the pricing above, that is the case for treating the medication decision as clinical and the provider decision as commercial. They are not the same choice.
Gala vs IVIM Health: common questions
Is IVIM Health cheaper than Gala?
Yes, on the ongoing rate. IVIM Health runs $174/mo once promotional pricing ends, against $249/mo at Gala — a difference of 43%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Which costs less over a year, Gala or IVIM Health?
IVIM Health, at roughly $2,013 for twelve months against $2,148 at Gala, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Does Gala or IVIM Health charge a membership fee?
IVIM Health runs a membership-plus-medication model, so the monthly total is the membership plus whatever the medication costs on your plan. Gala charges $249/mo with no separate membership. When comparing the two, price the membership model at your expected maintenance dose rather than at the introductory rate.
How fast can I start with Gala compared with IVIM Health?
Gala advertises fully online, no in-office visits, with home delivery. IVIM Health advertises free consult, then clinician review, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do Gala and IVIM Health prescribe the same medication?
Both dispense compounded GLP-1 preparations. Gala lists compounded semaglutide and compounded tirzepatide and IVIM Health lists compounded semaglutide, so the molecules overlap even where the formulary does not match exactly.
Can I switch from Gala to IVIM Health later?
Nothing stops you. The friction is administrative rather than clinical: a new intake, a new prescriber, and a delivery gap if you time it badly. Move while you still have two weeks of medication in the fridge, and read the cancellation terms on any prepaid plan before you do.
Is Gala or IVIM Health better for a first GLP-1 prescription?
If this is your first GLP-1, the question is who answers when nausea arrives on day nine. Gala publishes provider check-ins and dose monitoring included, which is the more useful thing to buy at the start.
The verdict
On the numbers, IVIM Health wins the year: $2,013 against $2,148. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
The case for Gala is a direct-pay model with dose monitoring included rather than sold as an add-on. That is worth $11 a month to some patients and nothing at all to others — be honest about which you are.
The failure mode here is not picking the wrong platform; it is stopping treatment because the bill moved. Choose the one whose bill you can predict.
Keep comparing
- Gala vs He & She MDCoaching-supported vs medication-only
- Gala vs MaximusBudget vs premium
- Enhance MD vs IVIM HealthBudget vs premium
- Directmeds vs IVIM HealthPublished price vs quote-only
- Refills vs NoviLarge platform vs smaller platform
- JoinFridays vs LIV BodyLarge platform vs smaller platform
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Gala or IVIM Health, and does not sell treatment. Read our ranking methodology.